Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 21, 2012; 18(11): 1229-1234
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1229
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1229
High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice
Roy Nattiv, Janet M Wojcicki, Elizabeth A Garnett, Neera Gupta, Melvin B Heyman, Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco, CA 94143-0136, United States
Author contributions: All authors contributed equally to this work; Nattiv R, Wojcicki JM, Garnett EA and Heyman MB designed the research; Nattiv R, Wojcicki JM, Garnett EA and Heyman MB performed the research; Nattiv R, Wojcicki JM, Garnett EA, Gupta N and Heyman MB contributed to the analysis; Nattiv R, Wojcicki JM, Garnett EA, Gupta N and Heyman MB wrote the paper.
Supported by DK060617 (MBH); DK080825 (JMW); DK077734 (NG); CCFA Career Development Award (NG); and NIH/NCRR UCSF-CTSI Grant, No. UL1 RR024131
Correspondence to: Melvin B Heyman, MD, MPH, Professor, Anita Ow Wing Endowed Chair, Department of Pediatrics, UCSF Benioff Children’s Hospital, 500 Parnassus Ave, MU 4 East, Box 0136, University of California, San Francisco, CA 94143-0136, United States. mheyman@peds.ucsf.edu
Telephone: +1-415-4760820 Fax: +1-415-4761343
Received: April 14, 2011
Revised: July 11, 2011
Accepted: July 18, 2011
Published online: March 21, 2012
Revised: July 11, 2011
Accepted: July 18, 2011
Published online: March 21, 2012
Core Tip